$CCEP

Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.

Original reporting
Published Aug 6, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$CCEPNeutralMed
01

Why it matters

Traders can update expectations for 2026 margins and growth durability using the call’s quantified assumptions: 6 fewer trading days in H2, cost of sales per unit case rising 1.5% full-year, and continued capex/cooler placements plus AI-enabled promotional pricing decisions.

02

Market read

Earnings-call guidance reaffirmation with specific H2 headwinds and cost step-up assumptions provides actionable inputs for positioning around 2026 earnings and margin expectations.

03

What to watch

The Suntory alcohol brand exit created a 1% first-half revenue headwind; if non-alcohol growth does not fully mask that gap, the revenue-per-case sustainability in Europe could be weaker than implied.

Relevance 7/10Novelty 6/10Timing: today, earnings call guidance reaffirmation and H2 assumptions

Background

The piece summarizes CCEP’s Q2 2026 earnings call, focusing on volume and revenue-per-case drivers, regional execution, margin/cost assumptions, and outlook for 2026.

Company-level read

Ticker impact

$CCEPNeutralMedium confidence
Context

CCEP reaffirmed full-year 2026 guidance while detailing Q2 revenue-per-case growth, H2 trading-day headwind, and cost-of-sales per case outlook.

Expected impact

Likely modest post-earnings drift rather than a sharp repricing, unless traders focus on the 6 fewer trading days and 1.5% cost-of-sales per case rise.

Evidence & confidence

The article is an earnings call summary with maintained guidance and specific operating assumptions (trading days, cost-of-sales per case, capex/cooler placements). It is decision-relevant but not a surprise print or new regulatory/transaction catalyst.

Market effects

Reinforces that beverage peers may sustain mix-led growth via zero sugar and energy categories while managing promotional mechanics and cost inflation.

Highlights Southeast Asia execution (Indonesia route-to-market, Philippines margin target) as a key swing factor for future earnings quality.

World Cup activation and AI-driven commercial decisioning suggest continued investment in brand and data tooling across Europe and emerging markets.

Counterpoint

The maintained guidance may still embed risk if the Philippines excise tax changes or Middle East volatility impacts costs more than assumed, offsetting the margin expansion narrative.

Key entities

  • Coca-Cola Europacific Partners PLC

    Subject of the earnings call summary, including reaffirmed 2026 guidance and detailed operating assumptions.

  • Monster

    Mentioned as driving energy category outperformance with Monster volumes growing at twice the category rate.

  • KIRA

    AI agent used to synthesize Nielsen and internal data to accelerate promotional pricing and cooler-space decisions.

  • FIFA World Cup

    Largest-ever activation program cited as driving brand engagement and transaction growth.

Related articles

$CCEPMedAI 8/10

Revenue Tops €10.7bn In Coca-Cola Europacific Partners’ H1

Coca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported first-half 2026 results on an earnings call. Revenue rose 6.1% to EUR 10.7B, operating profit increased 8.1% to EUR 1.5B, and diluted EPS rose 10.6% to EUR 2.20. Free cash flow was EUR 435M, with full-year guidance reaffirmed and EUR 600M of a EUR 1B buyback completed.

$CCEPMed

Coca-Cola Europacific shares lose fizz after interim results

Coca-Cola Europacific Partners reported higher first-half profit and reaffirmed 2026 guidance, but shares fell 4.3% to 7,710p after interim results. Revenue rose 4.4% to €10.7bn, operating profit increased 6.9% to €1.5bn, and diluted EPS grew 9.1% to €2.17. Guidance: currency-neutral revenue growth 3% to 4%, operating profit growth around 7%, free cash flow at least €1.7bn.

$CCEPMedAI 8/10

Coca-Cola Europacific Partners plc Announces Results for The Six Months Ended 3 July 2026

Coca-Cola Europacific Partners (CCEP) reported results for the six months ended 3 July 2026. Days-adjusted group volume rose 2.2% (Europe +1.6%, APS +3.5%). H1 revenue was +4.4% reported, comparable operating profit €1,481m (+8.1%), comparable diluted EPS €2.20 (+10.6%), and free cash flow €435m. Interim dividend was €0.82. FY26 guidance was reaffirmed.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.